# An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.

> **NCT00343226** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 48 (actual)

## Conditions studied

- Liver Transplantation

## Interventions

- **DRUG:** Basiliximab

## Key facts

- **NCT ID:** NCT00343226
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-05
- **Primary completion:** 2005-04
- **Final completion:** —
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2010-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00343226

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00343226, "An Open, Randomized Pilot Study to Evaluate the Use of Basiliximab With an Optimized Cyclosporine Dosing on Renal Function in "de Novo" Liver Transplantation.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00343226. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*